Commissioner Bio
Dr. Michelle Rozo
Dr. Michelle Rozo is currently serving as Vice Chair of the National Security Commission on Emerging Biotechnology, a U.S. legislative branch advisory entity charged with conducting a thorough review of how advancements in emerging biotechnology and related technologies will shape current and future activities of the Department of Defense. Dr. Rozo is also Vice President of Technical Capabilities at In-Q-Tel, a non-profit strategic investor that accelerates the development and delivery of cutting-edge technologies to enhance the national security of the United States. From 2021 to 2022 she was Director of Technology and National Security at the U.S. National Security Council, where she advised the President and National Security Advisor on biotechnology and national security policy, and was also previously the Principal Director for Biotechnology within the Office of the Under Secretary of Defense for Research & Engineering at the Department of Defense.
Dr. Rozo is a molecular biologist by training and studied severe infectious diseases as a staff scientist with the Naval Medical Research Center in Fort Detrick, Maryland. She holds a Ph.D. in Biology from the Cell, Molecular, Developmental Biology and Biophysics Program at the Johns Hopkins University and a B.A. in Biology from Northwestern University.
